Kaitlyn M. Le

Dr. Priscilla Merriam discusses how sarcomas can be mistaken for benign growths like lipomas and fibroids, and why asking about a biopsy can matter before surgery.

At least half of patients get nervous before a follow-up scan. Dr. Geoffrey Pelz explains why that is common, what he wants patients to hear at the first visit and how much lung cancer treatment has shifted in 15 years.

An incidental CT scan revealed stage 1A lung cancer. After robotic surgery at Hackensack University Medical Center, Carolyn Rothfeld describes a recovery that took longer than she expected.

After receiving a Stage 1 lung cancer diagnosis, Carolyn Rothfeld underwent robotic surgery to remove part of her lung and is back to her exercise routine nine months later.

Learn how Talvey plus Tecvayli cut the risk of myeloma progression or death by 89%, how the combination is given and what it may mean for daily life.

Dr. Ajay Nooka discusses the MonumenTAL-6 trial and explains what the promising Tecvayli plus Talvey results could mean for patients with relapsed multiple myeloma.

Patients with advanced biliary tract cancer lived longer on Imfinzi (durvalumab) plus chemotherapy than on chemotherapy alone, according to four-year follow-up data from the phase 3 TOPAZ-1 trial.

Tafinlar plus Mekinist extended progression-free survival to 12.8 months vs. 3.7 months with placebo in BRAF V600E-positive thyroid cancer.

Patients with advanced stomach cancer lived longer on sonesitatug vedotin than on standard treatment, according to new trial results.

Tecvayli plus Talvey cut the risk of disease progression or death by 89% in patients with relapsed multiple myeloma, according to new trial results.